Sorafenib (Tosylate)
Detailed Description
Sorafenib (Tosylate)Sorafenib tosylate (BAY 43-9006) is a potent inhibitor of Raf-1 with IC50 values of 6 nM, 22 nM and 90 nM for Raf-1, B-Raf, and VEGFR2 respectively, BAY 43-9006 suppresses both wild-type and V599E mutant BRAF activity in vitro.
IC50 Value: 6 nM (Raf-1); 22 nM (B-Raf); 90 nM (VEGFR2) [1]
Target: Raf-1
Sorafenib is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).
Target:Raf
Product Links:http://www.medchemexpress.cn/sorafenib-tosylate.html
Permanent link:http://www.medchemexpress.com/Sorafenib-Tosylate.html